SynCore Biotechnology Co.,Ltd (4192.TWO)
TWD 30.0
(0.0%)
TWD 30.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.11 Million TWD | -97.05% |
| 2022 | 71.75 Million TWD | -42.8% |
| 2021 | 125.45 Million TWD | -45.18% |
| 2020 | 228.83 Million TWD | 472.09% |
| 2019 | 40 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 12.66 Million TWD | -15.54% |
| 2024 Q1 | 14.99 Million TWD | 609.41% |
| 2023 Q4 | 2.11 Million TWD | -52.88% |
| 2023 FY | 2.11 Million TWD | -97.05% |
| 2023 Q3 | 4.48 Million TWD | -93.39% |
| 2023 Q2 | 67.88 Million TWD | -2.3% |
| 2023 Q1 | 69.48 Million TWD | 15.8% |
| 2022 FY | 71.75 Million TWD | -42.8% |
| 2022 Q4 | 60 Million TWD | 0.0% |
| 2021 FY | 125.45 Million TWD | -45.18% |
| 2020 FY | 228.83 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 99.475% |
| Level Biotechnology Inc. | 13.5 Million TWD | 84.343% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 99.718% |
| GlycoNex Incorporation | 900 Thousand TWD | -134.889% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 99.178% |
| OBI Pharma, Inc. | 501.05 Million TWD | 99.578% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 99.34% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 99.255% |
| Visgeneer Inc. | 158.6 Million TWD | 98.667% |
| Neith Corporation | 3.54 Million TWD | 40.299% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 83.236% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.893% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -80.529% |
| Enimmune corporation | 45.73 Million TWD | 95.378% |
| TaiRx, Inc. | 12.28 Million TWD | 82.793% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 96.368% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 99.46% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 64.157% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 80.422% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 97.439% |
| RBC Bioscience Corporation | 487.36 Million TWD | 99.566% |
| NaviFUS Corp. | 32.69 Million TWD | 93.534% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | 41.147% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -292.937% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 85.294% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 84.133% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 98.137% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -142.989% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 83.853% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | 61.075% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 92.205% |
| Lin BioScience, Inc. | 42.87 Million TWD | 95.069% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -52.856% |
| AP Biosciences Inc | 82.07 Million TWD | 97.424% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 98.786% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.69% |
| EirGenix Inc. | 465.16 Million TWD | 99.546% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 98.536% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 99.709% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | 51.447% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 97.818% |
| VBI | - TWD | -Infinity% |
| BiOptic Inc. | 93.19 Million TWD | 97.732% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 99.493% |
| Sinew Pharma Inc. | 6.46 Million TWD | 67.296% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 98.922% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.927% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 79.632% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.853% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.469% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | 73.479% |
| TCI GENE Inc. | 6.79 Million TWD | 68.889% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 74.585% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 77.981% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 99.213% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 80.21% |
| PharmaEngine, Inc. | 14.8 Million TWD | 85.725% |
| Savior Lifetec Corporation | 270.37 Million TWD | 99.218% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 97.17% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 93.789% |
| Acepodia, Inc. | 273.81 Million TWD | 99.228% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 89.667% |